Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksSUDEEPPHRM
resources
SUDEEPPHRM
1,344.20+20.9 (+1.58%)
8 Sep, 12:00 AM

Annual Reports and Financial Documents

Sudeep Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20252026
Annual Reports—FY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Sudeep Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General6 Aug 2026
    General Update
    General Update
  2. Analyst / Investor Meet5 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Submission of Audio Recording of Earnings Call held on 05.08.2026
  3. AGM5 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Submission of E-voting and Scrutinizer''s Report for the 37th Annual General Meeting held on 04.08.2026
  4. Newspaper Publication5 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Submission of newspaper publication of Financials as on 30.06.2026
  5. Outcome of Board Meeting4 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Submission of Outcome of Board Meeting
  6. AGM4 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Submission of proceedings of the 37th Annual General Meeting held on 4th August 2026
  7. General29 Jul 2026
    Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nuvama Crossover Opportunities Fund ....
  8. Analyst / Investor Meet27 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation for Earnings call to be held on Wednesday, 5th August 2026
  9. Board Meeting25 Jul 2026
    Board Meeting Intimation for Adoption Of Unaudited Financials (Standalone & Consolidated) For The Quarter Ended 30Th June 2026
    Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the unaudited financials (standalone ....
  10. Newspaper Publication11 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Submission of Newspaper Advertisement for 37th AGM, E-voting and dividend information published in Business Standard (English) and Vadodara Samachar (regional language) on Saturday, 11th July, 2026.
  11. Record Date10 Jul 2026
    Intimation Of Record Date For Payment Of Final Dividend On Equity Shares For The Financial Year 2025-26
    Record date for payment of final dividend on equity shares for the FY 2025-26 is Thursday, 23rd July, 2026.
  12. General10 Jul 2026
    Letter To Shareholders In Relation To Integrated Annual Report Of The Company For The Financial Year 2025-26
    Letter to Shareholders in Relation to Integrated Annual Report of the Company for the Financial Year 2025-26
  13. Reg. 34 (1) Annual Report10 Jul 2026
    Reg. 34 (1) Annual Report.
    Submission of 37th Annual Report
  14. AGM10 Jul 2026
    Notice Of 37Th Annual General Meeting
    Intimation for 37th Annual General Meeting to be held on Tuesday, 4th August 2026 at 11:00 a.m.
  15. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201810 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Submission of Certificate under Regulation 74 (5) of SEBI (DP) Regulations for the Quarter ended 30.06.2026
  16. Change in Management26 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    This is to inform that the Board of Directors at their meeting held on 26th June 2026 has appointed Mr. Milin Mehta as an Additional Director of the Company with immediate effect.
  17. Outcome without intimation26 Jun 2026
    Board Meeting Outcome for Appointment Of Mr. Milin Mehta As An Additional Director (Non-Executive & Non-Independent)
    This is to inform that, the Board has appointed Mr. Milin Mehta as an Additional Director (Non-Executive & Non-Independent) w.e.f. 26.06.2026.
  18. Closure of Trading Window25 Jun 2026
    Closure of Trading Window
    Intimation for Closure of Trading Window w.e.f. 1St July 2026 for Adoption of un-audited Financial Results for the Quarter ended 30th June 2026.
  19. Reg.24(A)-Annual Secretarial Compliance27 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Submission of Annual Secretarial Compliance Report for FY 2025-26
  20. Analyst / Investor Meet23 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time, we herewith submit the participation of Company Officials ....

Frequently Asked Questions

Where can I download the annual report of Sudeep Pharma Ltd.?
Annual reports of Sudeep Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Sudeep Pharma Ltd.?
Quarterly earnings results and presentations of Sudeep Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Sudeep Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Sudeep Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Sudeep Pharma Ltd.?
Investor presentations and annual day presentations of Sudeep Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Sudeep Pharma Ltd.?
Corporate announcements and regulatory filings of Sudeep Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Sudeep Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Sudeep Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Sudeep Pharma Ltd.?
The ISIN (International Securities Identification Number) of Sudeep Pharma Ltd. is INE0QPI01025. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Sudeep Pharma Ltd. listed?
Sudeep Pharma Ltd. is listed on NSE and BSE. The NSE symbol is SUDEEPPHRM and the BSE code is -.
Where can I find the shareholding pattern of Sudeep Pharma Ltd.?
The quarterly shareholding pattern of Sudeep Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Sudeep Pharma Ltd. on Sharpely?
Share price data for Sudeep Pharma Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.